Treatment of the Depressed Alcoholic Patient
- 821 Downloads
Alcohol use disorders (AUDs) and depressive illnesses are highly prevalent, frequently co-occur, and are associated with worse outcomes when paired. The assessment and treatment of patients with co-occurring alcohol use disorders and depressive illnesses is wrought with many significant challenges. When it comes to advocating treatment guidelines for this dually-diagnosed population, the data are limited, but, nonetheless, do suggest that an integrated approach to patients presenting with co-occurring AUD and depressive symptoms can be efficacious. In this approach, ongoing evaluation and treatment are provided under one roof according to the evolving needs of each patient. Utilizing antidepressant medications in conjunction with psychosocial therapies may augment overall treatment efficacy; data also suggest that combining and tailoring psychosocial therapies, such as motivational enhancement therapies, cognitive therapies, and twelve-step facilitation may further improve treatment outcomes for patients with co-occurring depressive and alcohol use disorders.
KeywordsDepression Mood disorders Substance use disorder SUD Alcohol Alcoholism Alcohol use disorder AUD Dual diagnosis Assessment Treatment Outcomes Pharmacotherapies Antidepressants Psychosocial therapies Motivational enhancement therapy Cognitive behavioral therapy Relapse prevention therapy Contingency management Twelve-step facilitation
Work on this article was supported, in part, by Grant K24 DA022288 from the National Institute on Drug Abuse (R. D. Weiss).
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.• Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Available via: http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm. Accessed 15 Aug 2012. Most recent survey data regarding prevalence and trends.
- 4.Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2011;131:233–42.PubMedCrossRefGoogle Scholar
- 12.Substance Abuse and Mental Health Services Administration. Behavioral Health is Essential to Health. Available via: http://store.samhsa.gov/shin/content/SMA11-PHYDE08022011/SMA11-PHYDE08022011.pdf. Accessed 15 Aug 2012.
- 18.DelBello MP, Strakowski SM. Understanding the problem of co-occurring mood and substance use disorders. In: Westermeyer JJ, Weiss RD, Ziedonis DM (eds) Integrated treatment for mood and substance use disorders. Baltimore, MD: Johns Hopkins University Press; 2003, pp. 17–42.Google Scholar
- 19.Meyer RE. How to understand the relationship between psychopathology and addictive disorders: another example of the chicken and the egg. In: Meyer RE, editor. Psychopathology and addictive disorders. New York: Guilford; 1986.Google Scholar
- 20.Weiss RD. The role of psychopathology in the transition from drug use to abuse and dependence. In: Glantz M, Pickens R (eds) Vulnerability to drug abuse. Washington, DC: American Psychological Association; 1992, pp. 137–148.Google Scholar
- 21.Busch A, Weiss RD, Najavits LM. Co-occurring substance use disorders and other psychiatric disorders. In: Frances RJ, Miller SI, Mack, editors. Clinical textbook of addictive disorders. 3rd ed. New York: Guilford Press; 2005. p. 271–302.Google Scholar
- 22.• Pettinati HM, Oslin DW, Kampman KM, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry. 2010;167:668–75. One of few DBRCTs looking at antidepressants and naltrexone for the depressed alcoholic population.PubMedCrossRefGoogle Scholar
- 23.• Hides LM, Elkins KS, Scaffidi A, et al. Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse? Med J Aust. 2011;195:S31–7. Specifically looking at patients with depression and substance misuse, this study showed that combination psychosocial treatments may help accelerate the treatment gains. PubMedGoogle Scholar
- 27.• Weiss RD, Smith Connery H. Integrated group therapy for bipolar disorder and substance abuse. New York: The Guilford Press; 2011. Model of integrated treatment of SUDs and co-occurring psychiatric illness.Google Scholar
- 31.Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV, Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009;117 Suppl 1:S26–43.PubMedCrossRefGoogle Scholar
- 32.Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP. Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med. 2001; Spec No Pharmacotherapy:1–86.Google Scholar
- 33.• Lovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72:1144–51. Well-done recent look at the literature on antidepressant use in patients with co-occurring depressive illness and AUD. CrossRefGoogle Scholar
- 46.Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R. VA CSP No. 425 Study Team. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, “Naltrexone in the treatment of alcoholism. Alcohol Clin Exp Res. 2008;32:85–91.PubMedCrossRefGoogle Scholar
- 48.Weiss RD. Pharmacotherapy for co-occurring mood and substance use disorders. In: Westermeyer JJ, Weiss RD, Ziedonis DM (eds) Integrated treatment for mood and substance use disorders. Baltimore, MD: Johns Hopkins University Press; 2003, p. 136.Google Scholar
- 49.Daley DC, Salloum IM, Thase ME. Integrated treatment using a recovery-oriented approach. In: Westermeyer JJ, Weiss RD, Ziedonis DM (eds) Integrated treatment for mood and substance use disorders. Baltimore, MD: Johns Hopkins University Press; 2003, pp. 68–79.Google Scholar
- 54.• Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, Salloum IM. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addict Behav. 2011;36:843–8. Two-year trial of manualized CBT/MET employed in an adolescent MDD/AUD co-occurring population with data indicating long term efficacy for an acute phase trial.PubMedCrossRefGoogle Scholar
- 59.Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series, No. 42. Center for Substance Abuse Treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2005. Report No.: (SMA) 05-3922.Google Scholar
- 60.Ziedonis DM, Krejci JA. Dual recovery therapy: blending psychotherapies for depression and addiction. In: Westermeyer JJ, Weiss RD, Ziedonis DM (eds) Integrated treatment for mood and substance use disorders. Johns Hopkins University Press; 2003, p. 103.Google Scholar
- 61.Beck AT, Wright FD, Newman CF, Liese BS. Cognitive therapy of substance abuse. New York: Guilford Press; 1993.Google Scholar
- 62.Brown RA, Ramsey SE, Kahler CW, Palm KM, Monti PM, Abrams D, Dubreuil M, Gordon A, Miller IW. A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptoms. J Stud Alcohol Drugs. 2011;72:286–96.PubMedGoogle Scholar
- 64.Marlatt GA, Parks GA, Witkiewitz K. Clinical Guidelines for Implementing Relapse Prevention Therapy: A Guideline Developed for the Behavioral Health Recovery Management Project, December 2002. Available via http://www.bhrm.org/guidelines/RPT%20guideline.pdf. Accessed 15 Aug 2012.
- 71.McKellar J, Stewart E, Humphreys K. Alcoholics Anonymous involvement and positive alcohol-related outcomes: Cause, consequence, or just a correlate? A prospective 2-year study of 2,319 alcohol-dependent men. J Consult Clin Psychol. 2003;71(2):302–8.Google Scholar
- 74.• Kelly JF, Stout RL, Magill M, Tonigan JS, Pagano ME. Mechanisms of behavior change in alcoholics anonymous: does Alcoholics Anonymous lead to better alcohol use outcomes by reducing depression symptoms? Addiction. 2010;105:626–36. Greater AA attendance led to reduction in depressive symptoms and better alcohol use outcomes. PubMedCrossRefGoogle Scholar